IMNN
Price
$0.88
Change
+$0.02 (+2.33%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
12.57M
20 days until earnings call
QTTB
Price
$1.55
Change
-$0.13 (-7.74%)
Updated
Apr 29, 04:59 PM (EDT)
Capitalization
20.55M
Ad is loading...

IMNN vs QTTB

Header iconIMNN vs QTTB Comparison
Open Charts IMNN vs QTTBBanner chart's image
Imunon
Price$0.88
Change+$0.02 (+2.33%)
VolumeN/A
Capitalization12.57M
Q32 Bio
Price$1.55
Change-$0.13 (-7.74%)
Volume$3.09K
Capitalization20.55M
IMNN vs QTTB Comparison Chart
Loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNN vs. QTTB commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNN is a Buy and QTTB is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (IMNN: $0.86 vs. QTTB: $1.68)
Brand notoriety: IMNN and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNN: 14% vs. QTTB: 179%
Market capitalization -- IMNN: $12.89M vs. QTTB: $18.97M
IMNN [@Biotechnology] is valued at $12.89M. QTTB’s [@Biotechnology] market capitalization is $18.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNN’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • IMNN’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, QTTB is a better buy in the long-term than IMNN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNN’s TA Score shows that 5 TA indicator(s) are bullish while QTTB’s TA Score has 2 bullish TA indicator(s).

  • IMNN’s TA Score: 5 bullish, 5 bearish.
  • QTTB’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, IMNN is a better buy in the short-term than QTTB.

Price Growth

IMNN (@Biotechnology) experienced а -3.21% price change this week, while QTTB (@Biotechnology) price change was -17.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was -2.03%, and the average quarterly price growth was -10.94%.

Reported Earning Dates

IMNN is expected to report earnings on Aug 13, 2025.

QTTB is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QTTB($20.6M) has a higher market cap than IMNN($12.6M). IMNN YTD gains are higher at: -9.474 vs. QTTB (-51.017). IMNN has higher annual earnings (EBITDA): -17.9M vs. QTTB (-44.5M). QTTB has more cash in the bank: 78M vs. IMNN (5.87M). IMNN has less debt than QTTB: IMNN (1.14M) vs QTTB (18.9M). IMNN (0) and QTTB (0) have equivalent revenues.
IMNNQTTBIMNN / QTTB
Capitalization12.6M20.6M61%
EBITDA-17.9M-44.5M40%
Gain YTD-9.474-51.01719%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.87M78M8%
Total Debt1.14M18.9M6%
FUNDAMENTALS RATINGS
IMNN vs QTTB: Fundamental Ratings
IMNN
QTTB
OUTLOOK RATING
1..100
5965
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8095
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (50) in the null industry is in the same range as IMNN (59) in the Medical Specialties industry. This means that QTTB’s stock grew similarly to IMNN’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that QTTB’s stock grew similarly to IMNN’s over the last 12 months.

QTTB's SMR Rating (100) in the null industry is in the same range as IMNN (100) in the Medical Specialties industry. This means that QTTB’s stock grew similarly to IMNN’s over the last 12 months.

IMNN's Price Growth Rating (80) in the Medical Specialties industry is in the same range as QTTB (95) in the null industry. This means that IMNN’s stock grew similarly to QTTB’s over the last 12 months.

IMNN's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as QTTB (100) in the null industry. This means that IMNN’s stock grew similarly to QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMNNQTTB
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 6 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

IMNN and

Correlation & Price change

A.I.dvisor tells us that IMNN and PCSA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMNN and PCSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
-2.00%
PCSA - IMNN
32%
Poorly correlated
-0.80%
STOK - IMNN
29%
Poorly correlated
-2.97%
DTIL - IMNN
28%
Poorly correlated
-4.13%
QTTB - IMNN
28%
Poorly correlated
-9.89%
AAVXF - IMNN
28%
Poorly correlated
N/A
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been closely correlated with CLRB. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
-9.89%
CLRB - QTTB
77%
Closely correlated
-4.39%
MESO - QTTB
51%
Loosely correlated
-3.43%
ADCT - QTTB
51%
Loosely correlated
+9.77%
STOK - QTTB
49%
Loosely correlated
-2.97%
ANAB - QTTB
41%
Loosely correlated
+3.04%
More